Advancements in Gastroenterology: A Weekly Review
Gastroenterologia
Gut Microbiome Therapies and Liver Disease Advances
Exploring groundbreaking research on gut microbiome therapies, liver disease advances, and novel approaches to gastroenterological conditions.
Bibliography
1. Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.
Authors: Davar D, Dzutsev AK, McCulloch JA, et al.
Journal: Science (New York, N.Y.), 2021 Feb 5
PMID: 33542131
DOI: 10.1126/science.abf3363
2. Emerging therapeutic regimens as alternatives to glucocorticoids for severe alcohol-associated hepatitis: a comprehensive review.
Authors: Kumar R, Elangovan S, Asrani SK
Journal: Clinical and molecular hepatology, 2026 Apr
PMID: 41715264
DOI: 10.3350/cmh.2025.1163
3. Epigenetic scars of CD8(+) T cell exhaustion persist after cure of chronic infection in humans.
Authors: Yates KB, Tonnerre P, Martin GE, et al.
Journal: Nature immunology, 2021 Aug
PMID: 34312547
DOI: 10.1038/s41590-021-00979-1
4. Burden of malnutrition and sarcopenia in patients with cirrhosis: pathophysiology, assessment, and management.
Authors: Miwa T, Shimizu M, Schnabl B
Journal: Clinical and molecular hepatology, 2026 Apr
PMID: 41398617
DOI: 10.3350/cmh.2025.1126
5. Colorectal cancer screening.
Authors: Leggett BA, Hewett DG
Journal: Internal medicine journal, 2015 Jan
PMID: 25582937
DOI: 10.1111/imj.12636
6. A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis.
Authors: Sanyal AJ, Bedossa P, Fraessdorf M, et al.
Journal: The New England journal of medicine, 2024 Jul 25
PMID: 38847460
DOI: 10.1056/NEJMoa2401755
7. Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH.
Authors: Loomba R, Sanyal AJ, Kowdley KV, et al.
Journal: The New England journal of medicine, 2023 Sep 14
PMID: 37356033
DOI: 10.1056/NEJMoa2304286
8. Colorectal cancer screening.
Authors: Leggett BA, Hewett DG
Journal: Internal medicine journal, 2015 Jan
PMID: 25582937
DOI: 10.1111/imj.12636
9. Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH.
Authors: Loomba R, Sanyal AJ, Kowdley KV, et al.
Journal: The New England journal of medicine, 2023 Sep 14
PMID: 37356033
DOI: 10.1056/NEJMoa2304286
10. Calprotectin in inflammatory bowel disease.
Authors: Khaki-Khatibi F, Qujeq D, Kashifard M, et al.
Journal: Clinica chimica acta; international journal of clinical chemistry, 2020 Nov
PMID: 32818491
DOI: 10.1016/j.cca.2020.08.025
Authors: Davar D, Dzutsev AK, McCulloch JA, et al.
Journal: Science (New York, N.Y.), 2021 Feb 5
PMID: 33542131
DOI: 10.1126/science.abf3363
2. Emerging therapeutic regimens as alternatives to glucocorticoids for severe alcohol-associated hepatitis: a comprehensive review.
Authors: Kumar R, Elangovan S, Asrani SK
Journal: Clinical and molecular hepatology, 2026 Apr
PMID: 41715264
DOI: 10.3350/cmh.2025.1163
3. Epigenetic scars of CD8(+) T cell exhaustion persist after cure of chronic infection in humans.
Authors: Yates KB, Tonnerre P, Martin GE, et al.
Journal: Nature immunology, 2021 Aug
PMID: 34312547
DOI: 10.1038/s41590-021-00979-1
4. Burden of malnutrition and sarcopenia in patients with cirrhosis: pathophysiology, assessment, and management.
Authors: Miwa T, Shimizu M, Schnabl B
Journal: Clinical and molecular hepatology, 2026 Apr
PMID: 41398617
DOI: 10.3350/cmh.2025.1126
5. Colorectal cancer screening.
Authors: Leggett BA, Hewett DG
Journal: Internal medicine journal, 2015 Jan
PMID: 25582937
DOI: 10.1111/imj.12636
6. A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis.
Authors: Sanyal AJ, Bedossa P, Fraessdorf M, et al.
Journal: The New England journal of medicine, 2024 Jul 25
PMID: 38847460
DOI: 10.1056/NEJMoa2401755
7. Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH.
Authors: Loomba R, Sanyal AJ, Kowdley KV, et al.
Journal: The New England journal of medicine, 2023 Sep 14
PMID: 37356033
DOI: 10.1056/NEJMoa2304286
8. Colorectal cancer screening.
Authors: Leggett BA, Hewett DG
Journal: Internal medicine journal, 2015 Jan
PMID: 25582937
DOI: 10.1111/imj.12636
9. Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH.
Authors: Loomba R, Sanyal AJ, Kowdley KV, et al.
Journal: The New England journal of medicine, 2023 Sep 14
PMID: 37356033
DOI: 10.1056/NEJMoa2304286
10. Calprotectin in inflammatory bowel disease.
Authors: Khaki-Khatibi F, Qujeq D, Kashifard M, et al.
Journal: Clinica chimica acta; international journal of clinical chemistry, 2020 Nov
PMID: 32818491
DOI: 10.1016/j.cca.2020.08.025
